Our finding that low p62 expression correlates with a more aggressive phenotype, worse prognosis and worse overall survival in EAC is in contrast to numerous studies done on other tumor entities [23–27], although there are also diverging reports about a potential prognostic impact of p62 [13]. This evidence concerns the gene SQSTM1 and neoplasm.